Reckitt Consumer Health Growth Helps Fuel Pharma Unit Divestment Buzz
This article was originally published in The Tan Sheet
Executive Summary
Reckitt Benckiser says it will focus on its consumer health business, led by the Mucinex OTC decongestant line, and other core units with strong sales and will review its slumping Rx business, including considering a sale.
You may also be interested in...
Reckitt Expands 'OTC' Business, China Presence With Mead Johnson
Marketing Enfamil and other Mead Johnson formula and nutritional brands, says RB CEO Rakesh Kapoor, is "very much in the core of what consumer health stands for," and also immediately doubles the size of the firm's consumer business.
Reckitt Expands 'OTC' Business, China Presence With Mead Johnson
Marketing Enfamil and other Mead Johnson formula and nutritional brands, says RB CEO Rakesh Kapoor, is "very much in the core of what consumer health stands for," and also immediately doubles the size of the firm's consumer business.
Sales & Earnings In Brief: Revlon, Reckitt, Kao Report At Half-Year Mark
Revlon remains optimistic that investments in its Almay brand will deliver, despite the brand’s struggling performance in the second quarter. More financial news in brief.